Related Experiment Videos
Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug
Abstract:
This study systematically analyzed the incidence and variety of adverse reactions to quinidine sulfate in 652 consecutively monitored hospitalized patients. Fourteen percent of the patients sustained adverse reactions of sufficient severity to warrant discontinuation of the drug. These reactions include GI intolerance, cardiac arrhythmias, fever with and without associated hepatic dysfunction or leukopenia, cinchonism, and hemolytic anemia. Cardiac arrhythmias were infrequent and, when present, generally occurred within 3 days of institution of quinidine therapy. There were no quinidine-related fatalities in this study group.
Insights
Adverse reactions to quinidine sulfate occurred in 14% of hospitalized patients, leading to drug discontinuation. Common side effects included GI intolerance, fever, and cinchonism, with no fatalities observed.
Area of Science:
- Pharmacology
- Clinical Medicine
- Drug Safety
Background:
- Quinidine sulfate is an antiarrhythmic medication used to treat cardiac arrhythmias.
- Understanding the adverse reaction profile of quinidine sulfate is crucial for patient safety.
- Hospitalized patients represent a population often requiring close monitoring for drug-induced adverse events.
Observation:
- A systematic analysis was conducted on 652 hospitalized patients receiving quinidine sulfate.
- The incidence and types of adverse reactions were meticulously documented.
- Patient data included demographics, treatment protocols, and observed side effects.
Findings:
- Fourteen percent of patients experienced adverse reactions severe enough to discontinue quinidine sulfate.
- Reported adverse reactions encompassed gastrointestinal intolerance, cardiac arrhythmias, fever, hepatic dysfunction, leukopenia, cinchonism, and hemolytic anemia.
- Cardiac arrhythmias were infrequent, typically manifesting within 3 days of initiating therapy; no fatalities were reported.
Implications:
- The findings highlight the importance of vigilant monitoring for quinidine sulfate adverse effects in hospitalized patients.
- Clinicians should be aware of the potential for diverse adverse reactions, including less common ones like hemolytic anemia.
- Risk-benefit assessment is essential when prescribing quinidine sulfate, particularly in vulnerable patient populations.